A 62-year-old woman with stage IIIA lung cancer faces complex diagnostic and treatment decisions, highlighting the importance ...

OU Health has become the first health system in Oklahoma to use Cytalux, a groundbreaking technology that helps detect cancer cells during surgery. Cytalux, an FDA-approved medication, is infused ...

Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical precision. Across operating rooms, scanners, and even blood tests, ...

The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung cancer in its earliest stages.

Hospital Sisters Health System is using artificial intelligence to help catch lung cancer earlier, but sometimes before ...

The latest update is out from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( ($HK:1349) ). Shanghai Fudan-Zhangjiang Bio-Pharmaceutical has ...

In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.

Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and ...

Identifying women eligible for lung cancer screening through screening mammography programs increases enrollment in lung cancer screening.

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...